Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report
Muir, Tobian, Bertino, Giulia, Groselj, Ales, Ratnam, Lakshmi, Kis, Erika, Odili, Joy, McCafferty, Ian, Wohlgemuth, Walter A, Cemazar, Maja, Krt, Aljosa, Bosnjak, Masa, Zanasi, Alessandro, Battista, Michela, de Terlizzi, Francesca, Campana, Luca G, Sersa, Gregor
Morphological features of breast cancer circulating tumor cells in blood after physical and biological type of isolation
Jesenko, Tanja, Modic, Ziva, Kuhar, Cvetka Grasic, Cemazar, Maja, Matkovic, Urska, Miceska, Simona, Varl, Jerneja, Kuhar, Anamarija, Kloboves-Prevodnik, Veronika
The biology and clinical potential of circulating tumor cells
Lozar, Taja, Gersak, Klara, Cemazar, Maja, Kuhar, Cvetka Grasic, Jesenko, Tanja
Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations
Muir, Tobian, Wohlgemuth, Walter A, Cemazar, Maja, Bertino, Giulia, Groselj, Ales, Ratnam, Lakshmi A, McCafferty, Ian, Wildgruber, Moritz, Gebauer, Bernhard, de Terlizzi, Francesca, Zanasi, Alessandro, Sersa, Gregor
Human papillomavirus-related oropharyngeal squamous cell carcinoma exhibits enhanced radiosensitivity despite limited activation of cytosolic DNA sensing pathways and innate immune responses
Levpuscek, Kristina, Jesenko, Tanja, Komel, Tilen, Brezar, Simona Kranjc, Sersa, Gregor, Cemazar, Maja, Strojan, Primoz
Between defence and delivery: the DNA sensing response to gene electrotransfer
Jesenko, Tanja, Omerzel, Masa, Heller, Loree C, Cemazar, Maja
Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression
Zager, Valerija, Cemazar, Maja, Hreljac, Irena, Lah, Tamara, Sersa, Gregor, Filipic, Metka